Biocon Biologics and Viatris launch Interchangeable Biosimilars SEMGLEE and Insulin Glargine Injection in US.
KEYPOINTS: Biocon Biologics and Viatris Inc have launched Semglee (insulin glargine-yfgn) injection, a branded product, and Insulin Glargine (insulin glargine-yfgn) injection, an…